Structure via PubChem · Public domain (PubChem)
protonitazene
Sign in to saveProtonitazene is a benzimidazole derivative with potent opioid effects which has been sold over the internet as a designer drug since 2019, and has been identified in various European countries, as well as Canada, the US and Australia. It has been linked to numerous cases of drug overdose, and is a Schedule I drug in the US.
Chemical data
- Formula
- C23H30N4O3
- Molecular weight
- 410.5 g/mol
- IUPAC name
- N,N-diethyl-2-[5-nitro-2-[(4-propoxyphenyl)methyl]benzimidazol-1-yl]ethanamine
- SMILES
- CCCOC1=CC=C(C=C1)CC2=NC3=C(N2CCN(CC)CC)C=CC(=C3)[N+](=O)[O-]
- InChIKey
- SJHUJFHOXYDSJY-UHFFFAOYSA-N
- XLogP
- 4.8
- Polar surface area
- 76.1 Ų
- H-bond donors
- 0
- H-bond acceptors
- 5
- Formal charge
- 0
via PubChem
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 410.23179082
Show 3 more facts
- canonical SMILES
- CCCOC1=CC=C(C=C1)CC2=NC3=C(N2CCN(CC)CC)C=CC(=C3)[N+](=O)[O-]
- Commons category
- Protonitazene
- chemical formula
- C₂₃H₃₀N₄O₃
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- See also
- References
Protonitazene is a benzimidazole derivative with potent opioid effects which has been sold over the internet as a designer drug since 2019, and has been identified in various European countries, as well as Canada, the US and Australia. It has been linked to numerous cases of drug overdose, and is a Schedule I drug in the US.
It was developed by a Swiss pharmaceutical company in the 1950s as an alternative to morphine, but was never adopted due to severe side effects.
Excerpted from Wikipedia’s “protonitazene” article, available under the CC BY-SA 4.0 licence.